GRUPO NOVARTIS vs. TEVA PHARMA S.L.U, MYLAN PHARMACEUTICALS, S.L, Ruling No. 113/2022 handed down by Commercial Court No. 10 of Barcelona on 7 March, 2022,
Spain
BackDate of JudgmentMarch 7, 2022Issuing AuthorityCommercial Court of BarcelonaLevel of the Issuing AuthorityFirst InstanceType of ProcedureJudicial (Civil)Subject MatterPatents (Inventions)Plaintiff/AppellantNOVARTIS FARMACEUTICA, S.A y otrosDefendant/RespondentTEVA PHARMA S.L.U, MYLAN PHARMACEUTICALS, S.L.Keywords
Medidas cautelares,
Patente farmacéutica,
Acciones de competencia desleal,
Secretos empresariales
Judgment/DecisionSpanishGRUPO NOVARTIS vs. TEVA PHARMA S.L.U, MYLAN PHARMACEUTICALS, S.L, Resolución No. 113/2022 decidida por el Juzgado de lo Mercantil 10 de Barcelona el 7 de marzo de 2022 PDFDOCXSummarySpanishGRUPO NOVARTIS vs. TEVA PHARMA S.L.U, MYLAN PHARMACEUTICALS, S.L, Resolución No. 113/2022 decidida por el Juzgado de lo Mercantil 10 de Barcelona el 7 de marzo de 2022 PDFDOCXRelevant Legislation